Literature DB >> 15986365

Selective cyclooxygenase 2 inhibitors and cardiovascular events.

Daniel H Solomon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15986365     DOI： 10.1002/art.21132

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  15 in total

Review 1.  Developments in post-marketing comparative effectiveness research.

Authors:  S Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2007-06-06       Impact factor: 6.875

Review 2.  Issues in the treatment of ankylosing spondylitis with non-steroidal anti-inflammatory drugs.

Authors:  Sjef van der Linden
Journal:  Wien Med Wochenschr       Date:  2008

3.  A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.

Authors:  F P Luyten; P Geusens; M Malaise; L De Clerck; R Westhovens; F Raeman; D Vander Mijnsbrugge; L Mathy; J P Hauzeur; F De Keyser; F Van den Bosch
Journal:  Ann Rheum Dis       Date:  2006-06-30       Impact factor: 19.103

4.  Symmetrical bis-tertiary amines as novel CXCR4 inhibitors.

Authors:  Renren Bai; Zhongxing Liang; Younghyoun Yoon; Shuangping Liu; Theresa Gaines; Yoonhyeun Oum; Qi Shi; Suazette Reid Mooring; Hyunsuk Shim
Journal:  Eur J Med Chem       Date:  2016-04-19       Impact factor: 6.514

5.  Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library.

Authors:  Renren Bai; Qi Shi; Zhongxing Liang; Younghyoun Yoon; Yiran Han; Amber Feng; Shuangping Liu; Yoonhyeun Oum; C Chris Yun; Hyunsuk Shim
Journal:  Eur J Med Chem       Date:  2016-11-24       Impact factor: 6.514

6.  Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

Authors:  Daniel H Solomon; Robert J Glynn; Kenneth J Rothman; Sebastian Schneeweiss; Soko Setoguchi; Helen Mogun; Jerry Avorn; Til Stürmer
Journal:  Arthritis Rheum       Date:  2008-08-15

Review 7.  Anaesthesiological problems in patients with rheumatoid arthritis undergoing orthopaedic surgeries.

Authors:  Barbara Lisowska; Lidia Rutkowska-Sak; Pawel Maldyk; Renata Cwiek
Journal:  Clin Rheumatol       Date:  2008-01-18       Impact factor: 2.980

8.  Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors.

Authors:  David L McCormick; Jonathan M Phillips; Thomas L Horn; William D Johnson; Vernon E Steele; Ronald A Lubet
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

9.  The Development of Novel Therapies for Rheumatoid Arthritis.

Authors:  Ling-Dong Quan; Geoffrey M Thiele; Jun Tian; Dong Wang
Journal:  Expert Opin Ther Pat       Date:  2008-07       Impact factor: 6.674

10.  [NSAIDs and COX-2-inhibitors: current status].

Authors:  C Kneitz; H P Tony; K Krüger
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.